BCA

Benchmark Capital Advisors Portfolio holdings

AUM $101M Turnover 16.91%
1-Year Est. Return 0.8%
This Fund
S&P 500
This Quarter Est. Return
+6.81%
1 Year Est. Return
-0.8%
3 Year Est. Return
+29.53%
5 Year Est. Return
+43.22%
10 Year Est. Return
–
AUM
$160M
AUM Growth
+$15.9M
Cap. Flow
+$6.81M
Cap. Flow %
4.26%
Top 10 Hldgs %
31.05%
Holding
148
New
17
Increased
36
Reduced
37
Closed
18
Avg Time Held
0.8 years
Top 10 Avg Time Held
0.7 years
Top 20 Avg Time Held
0.8 years

Top Sells

Rank Stock Value
1
QCOM icon
Qualcomm
QCOM
+$2.78M
2
LGND icon
Ligand Pharmaceuticals
LGND
+$1.4M
3
WU icon
Western Union
WU
+$1.03M
4
DD icon
Du Pont De Nemours E I
DD
+$845K
5
TEX icon
Terex
TEX
+$811K

Sector Composition

Rank Sector Weight
1 Miscellaneous 19.04%
2 Real Estate 13.42%
3 Energy 12.85%
4 Technology 11.92%
5 Healthcare 9.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
SHLD icon
101
DELISTED
Sears Holding Corporation
SHLD
$220K 0.14%
5,905
-1,382
-19% -$51.1K
2013 Q3
3 quarters
GS.PRB.CL icon
102
DELISTED
Goldman Sachs Group Depositary Shares (1/1000 Interest of 6.2% Non-Cum. Prfrd. Stock, Series B) Call
GS.PRB.CL
$217K 0.14%
8,700
– –
2014 Q1
1 quarter
BSJF
103
DELISTED
GUGGENGEIM BULLETSHARES 2015 HIGH YIELD CORPORATE BOND ETF
BSJF
$215K 0.13%
8,000
– –
2013 Q2
4 quarters
OXY icon
104
Occidental Petroleum
OXY
$61.4B
$205K 0.13%
+2,088
New +$196K
2014 Q2
0 quarters
CCEC icon
105
Capital Clean Energy Carriers
CCEC
$1.24B
$195K 0.12%
2,437
-143
-6% -$10.8K
2013 Q2
4 quarters
PCM icon
106
PCM Fund
PCM
$60.5M
$152K 0.1%
12,400
– –
2013 Q2
4 quarters
PXLW icon
107
Pixelworks
PXLW
$32.4M
$129K 0.08%
+1,417
New +$105K
2014 Q2
0 quarters
DXM
108
DELISTED
DEX MEDIA INC NEW COM STK (DE)
DXM
$111K 0.07%
+10,000
New +$96.3K
2014 Q2
0 quarters
RDI icon
109
Reading International Class A
RDI
$40.3M
$102K 0.06%
11,900
– –
2013 Q2
4 quarters
BLRX icon
110
BioLineRX
BLRX
$10.4M
$83K 0.05%
67
+34
+103% +$42.6K
2014 Q1
1 quarter
ATNY
111
DELISTED
API TECHNOLOGIES CORP. COMMON STOCK
ATNY
$53K 0.03%
19,500
– –
2013 Q3
3 quarters
PDL.B
112
DELISTED
PRESIDENTAL RLTY CL B
PDL.B
$19K 0.01%
350,200
– –
2013 Q2
4 quarters
CSX icon
113
CSX Corp
CSX
$89.4B
– –
-34,200
Closed -$330K –
CX icon
114
Cemex
CX
$13.7B
– –
-67,793
Closed -$732K –
IBM icon
115
IBM
IBM
$215B
– –
-3,264
Closed -$601K –
IYY icon
116
iShares Dow Jones US ETF
IYY
$3.02B
– –
-4,400
Closed -$209K –
LGND icon
117
Ligand Pharmaceuticals
LGND
$5.88B
– –
-33,342
Closed -$1.4M –
TEX icon
118
Terex
TEX
$5.97B
– –
-18,300
Closed -$811K –
TXN icon
119
Texas Instruments
TXN
$256B
– –
-7,000
Closed -$330K –
WU icon
120
Western Union
WU
$1.89B
– –
-62,800
Closed -$1.03M –
CGRN
121
DELISTED
Capstone Green Energy Corporation Common Stock
CGRN
– –
-150
Closed -$64K –
ARTX
122
DELISTED
Arotech Corporation
ARTX
– –
-22,500
Closed -$140K –
DD icon
123
DELISTED
Du Pont De Nemours E I
DD
– –
-13,268
Closed -$845K –
DARA
124
DELISTED
DARA BIOSCIENCES INC COM STK (DE)
DARA
– –
-26,100
Closed -$72K –
MPZ
125
DELISTED
MPC CORPORATION COM
MPZ
$0 ﹤0.01%
25,000
– –
2013 Q2
4 quarters

Similar funds

Benchmark Capital Advisors's Q2 2014 Portfolio in Review

As of Q2 2014, Benchmark Capital Advisors held 148 positions worth $160M, up 11% from $144M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Benchmark Capital Advisors deployed $6.81M of net new capital in Q2 2014, opening 17 new positions and adding to 36 existing holdings. Its largest new stake was SELECT INCOME REIT: 239,671 shares worth $3.12M.

By sector, the portfolio is most concentrated in Miscellaneous at 19% of assets, up from 18% a quarter earlier, followed by Real Estate and Energy.

On the sell side, the largest reduction was Qualcomm, an estimated $2.78M trimmed.

  • Benchmark Capital Advisors's largest Q2 2014 buy was SELECT INCOME REIT: 239,671 shares worth $3.12M.
  • Benchmark Capital Advisors added most to Yahoo Inc in Q2 2014, an estimated $3.35M increase.
  • Benchmark Capital Advisors's biggest Q2 2014 reduction was Qualcomm, cutting an estimated $2.78M.
  • Benchmark Capital Advisors fully exited Ligand Pharmaceuticals in Q2 2014, selling an estimated $1.4M.
  • Benchmark Capital Advisors's ten largest holdings make up 31% of its $160M portfolio in Q2 2014.
  • Benchmark Capital Advisors opened 17 new positions and closed 18 in Q2 2014.
  • Benchmark Capital Advisors's portfolio value rose 11% quarter-over-quarter to $160M.

Based on Benchmark Capital Advisors's 13F filing for Q2 2014, filed 6 Aug 2014.